In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …

More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

This is the first American Association for the Study of Liver Diseases (AASLD) practice
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …

Background & Aims The association between sarcopenia and prognosis in patients with
cirrhosis remains to be determined. In this study, we aimed to quantify the association …

Loss of muscle mass and function, or sarcopenia, is a common feature of cirrhosis and
contributes significantly to morbidity and mortality in this population. Sarcopenia is a main …

Background Sarcopenia is frequently found in patients with cirrhosis and is associated with
liver dysfunction, cirrhosis-related complications, and poorer quality of life. Purpose To …

Muscle alterations (myosteatosis and sarcopenia) are frequent in cirrhosis and related to
some complications including overt hepatic encephalopathy (HE). The aim of our study was …

Malnutrition is a common comorbidity in patients with cirrhosis. Its prognostic value is
indisputable as it greatly affects the evolution of liver diseases. It has a major impact on both …

Background & Aims Spontaneous portosystemic shunts (SPSS) frequently develop in liver
cirrhosis. Recent data suggested that the presence of a single large SPSS is associated with …

Computed tomography (CT) and magnetic resonance imaging (MRI) can quantify muscle
mass and quality. However, it is still unclear if CT and MRI derived measurements can be …